Literature DB >> 2176978

Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity.

P Nambi1, M Pullen, L C Contino, D P Brooks.   

Abstract

Measurement of endothelin receptors by binding assay was performed in rats treated with cyclosporine A (CYA). Cyclosporine A administration at 50 mg/kg i.p. for 4 days resulted in renal function impairment as indicated by a significant increase in serum creatinine concentration (from 0.46 +/- 0.02 to 0.61 +/- 0.03 mg/dl. P less than 0.01) and a significant decrease in 24 h creatinine clearance (from 0.65 +/- 0.04 to 0.41 +/- 0.02 ml/min per 100 g, P less than 0.01). Renal endothelin (ET) receptor density was significantly higher in CYA-treated rats (312 +/- 34 vs. 196 +/- 26 fmol/mg protein, P less than 0.01). These data support the possible involvement for endothelin in the increased renal vascular resistance associated with CYA-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2176978     DOI: 10.1016/0014-2999(90)90346-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Increased endothelin excretion in rats with renal failure induced by partial nephrectomy.

Authors:  D P Brooks; L C Contino; B Storer; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

2.  Absence of endothelin receptors and receptor mRNA in mammalian fibroblasts transformed with SV40 or ras oncogene.

Authors:  P Nambi; M R Mattern; H L Wu; M Pullen; P Nuthulaganti; G A Hofmann; C Kumar
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

3.  Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.

Authors:  D M Lanese; J D Conger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

Review 4.  Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.

Authors:  Navneet S Rehsia; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

5.  Divergent expression of EtA and EtB receptors in response to cyclosporine in mesangial cells.

Authors:  M Takeda; S Iwasaki; S E Hellings; H Yoshida; T Homma; V Kon
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

6.  Cyclophilin-dependent stimulation of transcription by cyclosporin A.

Authors:  T G Larson; D L Nuss
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

7.  Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.

Authors:  J J Maguire; R E Kuc; G O'Reilly; A P Davenport
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

8.  Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity.

Authors:  A Lo Russo; A C Passaquin; P André; M Skutella; U T Rüegg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

9.  Paracrine renal endothelin system in rats with liver cirrhosis.

Authors:  B Hocher; R Zart; F Diekmann; P Rohmeiss; A Distler; H H Neumayer; C Bauer; P Gross
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.